Abstract
A gas‐chromatography‐mass spectrometry (GC‐MS) method for the determination of plasma ibuprofen was developed. Plasma samples from cystic fibrosis (CF) patients receiving high‐dose ibuprofen therapy were analyzed by GC‐MS and the result compared to analysis by high‐performance liquid chromatography (reference method). Analysis of ibuprofen was sensitive to at least 5 mg/L, and the method was linear to 200 mg/L. Within‐run variations of plasma samples were 4.6% (131.7 ± 6.0 mg/L) and 5.4% (44.4 ± 2.4 mg/L), respectively. The between‐run variation was 9.3% (45.4 ± 4.2 mg/L) and 7.4% (88.0 ± 6.5 mg/L). This method is suited for routine clinical use for the monitoring of plasma ibuprofen levels in treatment of CF. It may be particularly applicable in pediatric laboratories, which are likely to possess GC‐MS capability. J. Clin. Lab. Anal. 11:336–339, 1997. © 1997 Wiley‐Liss, Inc.
Keywords: ibuprofen, anti‐inflammatory agents, cystic fibrosis, NSAIDS, GC‐MS
References
- 1. Konstan MW, Hoppel CL, Chai B, Davis PB: Ibuprofen in children with cystic fibrosis: Pharmacokinetics and adverse effects. J Pediatr 118: 956–964, 1991. [DOI] [PubMed] [Google Scholar]
- 2. Konstan MW, Vargo KM, Davis PB: Ibuprofen attenuates the inflammatory response to Pseudomonas aeruginosa in a rat model of chronic pulmonary infection: Implications for antiinflammatory therapy in cystic fibrosis. Am Rev Respir Dis 141: 186–192, 1990. [DOI] [PubMed] [Google Scholar]
- 3. Okrent DG, Lichtenstein AK, Ganz T: Direct cytotoxicity of polymorphonuclear leukocyte granule proteins to human lung‐derived cells and endothelial cells. Am Rev Respir Dis 141: 179–185, 1990. [DOI] [PubMed] [Google Scholar]
- 4. Colton HR: Airway inflammation in cystic fibrosis. N Engl J Med 332: 886–887, 1995. [DOI] [PubMed] [Google Scholar]
- 5. Thompson AB, Smits WL, Fick RB: Immunomodulatory therapies for cystic fibrosis. Semin Resp Infect 7: 218–226, 1992. [PubMed] [Google Scholar]
- 6. Maderazo EG, Breaux SP, Woronick CL: Inhibition of human polymorphonuclear leukocyte cell responses by ibuprofen. J Pharm Sci 73: 1403–1406, 1984. [DOI] [PubMed] [Google Scholar]
- 7. Konstan MW, Byard PJ, Hoppel CL, Davis PB: Effect of high‐dose ibuprofen in patients with cystic fibrosis. N Engl J Med 332: 848–854, 1995. [DOI] [PubMed] [Google Scholar]
- 8. Minkler PE, Hoppel CL: Determination of ibuprofen in human plasma by high‐performance liquid chromatography. J Chromatogr 428: 388–394, 1988. [DOI] [PubMed] [Google Scholar]
- 9. Whitlam JB, Vine JH: Quantitation of ibuprofen in biological fluids by gas chromatography‐mass spectrometry. J Chromatogr 181: 463–468, 1980. [DOI] [PubMed] [Google Scholar]
- 10. Jack DS, Rumble RH, Davies NW: Enantiospecific gas chromatographic‐mass spectrometric procedure for the determination of ketoprofen and ibuprofen in synovial fluid and plasma: application to protein binding studies. J Chromatogr 584: 187–197, 1992. [DOI] [PubMed] [Google Scholar]
- 11. Aravind MK, Miceli JN, Kauffman RE: Determination of ibuprofen by high‐performance liquid chromatography. J Chromatogr 308: 350–353, 1984. [DOI] [PubMed] [Google Scholar]
- 12. Albert KS, Raabe A, Garry M, Antal EJ, Gillespie WR: Determination of ibuprofen in capillary and venous plasma by high‐performance liquid chromatography with ultraviolet detection. J Pharm Sci 73: 1487–1489, 1984. [DOI] [PubMed] [Google Scholar]
- 13. Hoffman DJ: Rapid GLC determination of ibuprofen in serum. J Pharm Sci 66: 749–750, 1977. [DOI] [PubMed] [Google Scholar]
- 14. Kaiser DG, Van Giessen GJ: GLC determination of ibuprofen [(±)‐2‐(p‐isobutylphenyl)propionic acid] in plasma. J Pharm Sci 63: 219–221, 1974. [DOI] [PubMed] [Google Scholar]
- 15. Heikkinen L: Silica capillary gas chromatographic determination of ibuprofen in serum. J Chromatogr 307: 206–209, 1984. [DOI] [PubMed] [Google Scholar]